Migration Summary - Content

Example (Confluence API)

Displaying 1 - 116 of 116

Event

Displaying 91 - 100 of 401
Event Date
Controlled Terminology Updates for Q1 -
Public Training in Reading, UK -
CDISC for Newcomers - Are You New Here? -
Myths and Truths: Insight into CDISC’s Controlled Terminology Magic -
Webinar: The FDA Study Data Technical Conformance Guide v4.4 -
PHUSE Europe Connect -
Public Training in Copenhagen, Denmark -
SCDM EMEA Conference 2019 -
2019 CDISC US Interchange -
Why Data Sharing and Data Standardization Matter -

Newsletter Article

Displaying 91 - 100 of 486
CDISC Japan User Group Update
CDISC Japan User Group Update
CDISC Japan User Group Update
CDISC Japan User Group: Seeking Ways to Streamline Medical and Drug Development Now and in the Future
CDISC Japan User Group: Workshop Webinar and Monthly Meeting Fourth Quarter 2020
CDISC Japanese User Group (CJUG) Update
CDISC Launches Free Online Course for Newcomers to Public Review Fourth Quarter 2019
CDISC Launches Task Force to Rapidly Develop Standards for COVID-19 Second Quarter 2020
CDISC Launches Task Force to Rapidly Develop Standards for COVID-19 First Quarter 2020
CDISC Library

News

Displaying 61 - 66 of 66

Testimonials

Displaying 71 - 73 of 73

Knowledge Base

Displaying 1 - 56 of 56
A Short History of CDISC and SAS Transport Files Yes
Are These Findings Just Repeats or Were They Scheduled at Time Points? Yes
Assessing Causality Yes
Avoiding SDTM and ADaM Dataset and Variable Name Conflicts Yes
Can I add this variable to my SDTMIG dataset? Yes
CDISC ADaM Phases, Periods, and Subperiods: A Case Study No
CDISC-Annotated CRF Repository in Japanese Yes
Changing Event Severity Yes
Concept Maps for a Finding with Increasing Levels of Detail Yes
Concept Maps for Adverse Events with Increasing Levels of Detail Yes
Concept Maps for Substance Administration with Increasing Levels of Detail Yes
Considerations for Using CDISC Standards in Observational Studies Yes
Controlled Terminology: FAQs Yes
Country Coding Yes
Do I have to use the variable labels in the SDTMIG? Yes
Does QNAM Need to Start with a Domain Code? Yes
Domain vs. Dataset: What's the Difference? Yes
Domains are Topic-based, Except When They're Based on Structure Yes
How Do I Represent a Pre-specified Finding? Yes
How should I represent whether a physical exam was performed in SDTM? Yes
Implementation of COVID-19 Pandemic Impact Standards No
IS Domain Scope Update for the SDTMIG v3.4: A Development History and the Difficulties of Standardizing Complicated Biological Processes Yes
LOINC and the SDTM Yes
Making Clinical Data Acquisition Standards Harmonization (CDASH) Electronic Case Report Forms Available on the REDCap Shared Data Instrument Library No
Making Sense of the Various ADaM Documents Yes
Oncology Disease Response (RS) Supplements Yes
Pre-specified Events and Pre-specified Findings Yes
Providing Review-Ready Results in SDTM Yes
QA Knowledge Base No
SDTM and CDASH: Why You Need Both Yes
SDTM Structure Diagrams Yes
SDTM Timing Variables for Pre-study Findings Yes
Sex and Gender Yes
Special Values: "MULTIPLE" and "OTHER" Yes
Standardized Lab Units Yes
Study Subject Site Transfers Example Yes
Study Subject vs. Experimental Unit Yes
Subject Visits and COVID-19 Yes
TAUG Examples of SDTM Domains Yes
Test Academic No
Test Academic - Masquerade No
The Magic that Happens between CDASH and SDTM Yes
Translating CDASH "PRIOR" and "ONGO" to SDTM relative timing variables Yes
UCUM and CDISC Codelists Yes
Use of Fast Healthcare Interoperability Resources (FHIR) in the Generation of Real World Evidence (RWE) Yes
Use of FHIR in Clinical Research: From Electronic Medical Records to Analysis Yes
Use of HL7 FHIR as eSource to Pre-populate CDASH Case Report Forms using a CDISC ODM API Yes
Variable Metadata Has Changed in SDTM v2.0. How Does This Affect SDTMIG v3.4? Yes
What Do We Mean When We Say Provisional? Yes
When Did That Happen? A Brief Guide to Representing Timing in SDTM. Yes
When Would I Use ISO8601 Interval Format? Yes
Where Does My Lab Data Go in SDTMIG v3.4? Yes
Why Are Certain SDTM Variables "Not for Use in Human Clinical Trials"? Yes
Why is an Image like a Specimen? Yes
Why Not Just Use SNOMED? Yes
Why Would a Standards Development Organization Make Non-standard Variables Available on their Website? Yes

Resource

Displaying 41 - 48 of 48

Therapeutic Area Version

Displaying 71 - 73 of 73

Company

Displaying 91 - 100 of 423
Membership Level Company Address
Corcept Therapeutics Gold

123 Main Street
Anytown, WA 98233
United States

Cota Enterprises, Inc. Gold

16570 46th Street
McLouth, KS 66054
United States

CPC Clinical Research Gold

Aurora, Colorado 80045
United States

CRC Pharma Gold

Parsippany, New Jersey 07054
United States

CRISALIS Gold

800 Research Pkwy
Ste 338
Oklahoma City, OK 73104
United States

CRISPR Therapeutics Gold

610 Main Street North
Cambridge, MA 02139
United States

Critical Path Institute Platinum

United States

Cross Research SA Gold

Via Lavizzari 18
6850 Mendrisio
Switzerland

CRS Clinical Research Services Mannheim GmbH Gold

2067269 Grünstadt
Germany

CRScube Inc. Gold

#807 R&D Tower(Nuritkum Square), 396
World cup buk-ro
Mapo-gu
Seoul
03925
South Korea

Courses

Displaying 41 - 49 of 49

Instructors

Displaying 41 - 44 of 44

Team

Displaying 51 - 55 of 55
Structure Not Ready